dopa < dopamine < dopaminergic

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 95.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000040 (2013)	Isabelle Boileau [Canada, Niger] ; Doris Payer [Canada] ; Bindiya Chugani [Canada] ; Daniela Lobo [Canada] ; Arian Behzadi [Canada] ; Pablo M. Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jerry Warsh [Canada] ; Stephen J. Kish [Canada] ; Martin Zack [Canada]	The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]‐(+)‐propyl‐hexahydro‐naphtho‐oxazin and [11C]raclopride
000290 (2012)	Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis]	Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's disease
000291 (2012)	Christel Renoux [Canada] ; Sophie Dell'Aniello [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada]	Dopamine agonist use and the risk of heart failure
000492 (2010)	Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada]	Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
000627 (2010)	Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas]	Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
000628 (2010)	André R. Troiano [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Vesna Sossi [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function
000629 (2010)	J. Linnet [Danemark] ; E. Peterson [Danemark] ; D. J. Doudet [Danemark, Canada] ; A. Gjedde [Danemark] ; A. M Ller [Danemark]	Dopamine release in ventral striatum of pathological gamblers losing money
000769 (2009)	Stéphane Potvin [Canada] ; Sylvain Grignon [Canada] ; Serge Marchand [Canada]	Human evidence of a supra‐spinal modulating role of dopamine on pain perception
000778 (2009)	Philip Seeman [Canada] ; Hong-Chang Guan [Canada]	Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors
000779 (2009)	Philip Seeman [Canada] ; Hong-Chang Guan [Canada]	Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor
000792 (2009)	Marc Morissette [Canada] ; Thérèse Di Paolo [Canada]	Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys
000794 (2009)	Satoshi Suo [Canada] ; Joseph G. Culotti [Canada] ; Hubert H M. Van Tol [Canada]	Dopamine counteracts octopamine signalling in a neural circuit mediating food response in C. elegans
000795 (2009)	Philip Seeman [Canada]	Dopamine D2High receptors measured ex vivo are elevated in amphetamine‐sensitized animals
000872 (2008)	Annie Larouche [Canada] ; Patrick Berube [Canada] ; Philippe Sarret [Canada] ; Sylvain Grignon [Canada]	Subacute H2O2, but not poly(IC), upregulates dopamine D2 receptors in retinoic acid differentiated SH‐SY5Y neuroblastoma
000908 (2008)	Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine]	Memantine agonist action at dopamine D2High receptors
000925 (2008)	Yuhua Jiang [Canada, République populaire de Chine] ; Lin Pei [Canada] ; Shupeng Li [Canada] ; Min Wang [Canada] ; Fang Liu [Canada]	Extracellular dopamine induces the oxidative toxicity of SH‐SY5Y cells
000936 (2008)	Philip Seeman [Canada]	Dopamine D2High receptors on intact cells
000937 (2008)	Philip Seeman [Canada]	Dopamine D2High receptors moderately elevated by sertindole
000938 (2008)	Philip Seeman [Canada]	Dopamine D2High receptors moderately elevated by bifeprunox and aripiprazole
000A56 (2007)	Philip Seeman [Canada] ; Patrick N. Mccormick [Canada] ; Shitij Kapur [Canada]	Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO
000A70 (2007)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "dopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    dopamine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022